SEI Investments’s Beam Therapeutics BEAM Stock Holding History

SEI Investments’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$393K	Buy	16,059 +4,608	+40%	+$128K	﹤0.01%	2752
2026 Q2	$393K	Hold	11,451	–	–	﹤0.01%	2746
2026 Q1	$273K	Sell	11,451 -16	-0.1%	-$444	﹤0.01%	2856
2025 Q4	$318K	Buy	11,467 +16	+0.1%	+$408	﹤0.01%	2710
2025 Q3	$278K	Buy	+11,451	New	+$228K	﹤0.01%	2495
2023 Q3	–	Sell	-7,142	Closed	-$228K	–	2628
2023 Q2	$228K	Buy	+7,142	New	+$232K	﹤0.01%	2436
2023 Q1	–	Sell	-5,693	Closed	-$223K	–	2688
2022 Q4	$223K	Sell	5,693 -3,536	-38%	-$158K	﹤0.01%	2312
2022 Q3	$440K	Buy	+9,229	New	+$526K	﹤0.01%	2145
2021 Q3	–	Sell	-1,740	Closed	-$224K	–	2557
2021 Q2	$224K	Sell	1,740 -8,679	-83%	-$692K	﹤0.01%	2420
2021 Q1	$851K	Hold	10,419	–	–	﹤0.01%	1820
2020 Q4	$851K	Buy	+10,419	New	+$512K	﹤0.01%	1758

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $17.4B AUM 41.01% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Nikko Asset Management Americas New York $8.04B AUM 33.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

SEI Investments's BEAM Position: Q3 2026 in Review

SEI Investments increased its Beam Therapeutics (BEAM) stake by 40% in Q3 2026, buying an estimated $128K and bringing the position to 16,059 shares worth $393K. The position accounts for ﹤0.01% of the portfolio, ranked #2752.

SEI Investments first reported a position in BEAM in Q4 2020 and has held it in 11 quarters since. The position peaked at $851K in Q1 2021. 191 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.

SEI Investments held 16,059 shares of Beam Therapeutics worth $393K as of Q3 2026.
SEI Investments bought 4,608 Beam Therapeutics shares in Q3 2026, an estimated $128K.
Beam Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q3 2026, its #2752 holding.
SEI Investments first reported a position in Beam Therapeutics in Q4 2020 and has held it in 11 quarters since.
SEI Investments's Beam Therapeutics position peaked at $851K in Q1 2021.
191 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.

Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.